Evidence map›Paper›PMID 40123961›Full record

ArticleClinical kidney journal2025

Clinicopathological features and predictors of anti-GBM disease combined with membranous nephropathy.

Yuanyuan Wu, Lijie Zhang, Zhanzheng Zhao

Abstract read
In one paragraph

Article in Clinical kidney journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yuanyuan WuDepartment of Nephrology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.ORCID https://orcid.org/0009-0008-8818-9624
Lijie ZhangDepartment of Nephrology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Zhanzheng ZhaoDepartment of Nephrology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.ORCID https://orcid.org/0000-0001-6079-1631

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Anti-glomerular basement membrane (anti-GBM) disease is a rare and life-threatening form of small vessel vasculitis that primarily affects the kidneys and lungs. In rare cases, it occurs with membranous nephropathy (MN). This study aimed to investigate the clinical manifestations, pathological features, prognosis and predictors of anti-GBM disease with MN. Methods: We enrolled 24 patients with combined anti-GBM disease and MN, and 69 patients with classic anti-GBM disease (without MN). We compared the clinical and pathological differences, as well as the prognoses between the two groups and attempted to identify predictors of anti-GBM disease combined with MN. Results: A greater proportion of patients with combined disease were male, had a history of smoking, and had nephrotic syndrome (NS). Compared with patients with classic anti-GBM disease, those with anti-GBM disease with MN presented improved renal function, higher hemoglobin and serum C3 levels, and significantly improved renal outcomes ( Conclusions: This study provides insights into the distinct clinical and pathological characteristics of anti-GBM disease with MN. The identification of predictors may contribute to the early recognition and management of these patients.

Indexed as

anti-GBM diseaseclinical manifestationmembranous nephropathypathologypredictors

Identifiers

PMID40123961
PMCPMC11926589

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.